Pavan Cheruvu is Chief Executive Officer of Sio Gene Therapies Inc.. Currently has a direct ownership of 203,109 shares of SIOX, which is worth approximately $0. The most recent transaction as insider was on Dec 08, 2021, when has been sold 14,884 shares (Common Stock) at a price of $1.42 per share, resulting in proceeds of $21,135. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 203K
0% 3M change
0% 12M change
Total Value Held $0

Pavan Cheruvu Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 08 2021
SELL
Payment of exercise price or tax liability
$21,135 $1.42 p/Share
14,884 Reduced 6.83%
203,109 Common Stock
Dec 08 2021
BUY
Grant, award, or other acquisition
-
37,567 Added 14.7%
217,993 Common Stock
Mar 23 2021
BUY
Open market or private purchase
$248,000 $2.48 p/Share
100,000 Added 35.66%
180,426 Common Stock
Mar 17 2021
BUY
Grant, award, or other acquisition
-
22,590 Added 21.93%
80,426 Common Stock
PC

Pavan Cheruvu

Chief Executive Officer
New York, NY

Track Institutional and Insider Activities on SIOX

Follow Sio Gene Therapies Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SIOX shares.

Notify only if

Insider Trading

Get notified when an Sio Gene Therapies Inc. insider buys or sells SIOX shares.

Notify only if

News

Receive news related to Sio Gene Therapies Inc.

Track Activities on SIOX